The ann. refers to a program and Capital structure which could mean that may-be Walter Reed have seen something they like and prepared to take over full funding for a % of any future sales. Another option a big pharma has seen something with the cholesteral drug that interests them and willing to fund future development. Both options would be non dilute and could affects Capital Structure This is just a different view on the possible funding arrangements.
The ann. refers to a program and Capital structure which could...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
0.001(1.37%) |
Mkt cap ! $13.27M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 8.3¢ | 7.3¢ | $60.72K | 782.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79991 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 70000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.5¢ |
Change
0.001 ( 2.74 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.3¢ | 561583 | ||
| Last updated 15.27pm 04/06/2024 ? | |||||
| NYR (ASX) Chart |